Health Economics and Outcomes Research (HEOR)

Overview
Benefits
Solution
Research Hub
Success Stories

Health-economics-outcomes-research-analytics

Health economics and outcomes research (HEOR)

Real-world evidence (RWE)-based treatment publications to meet the growing value-based pricing, market access, and reimbursement requirements.

DOWNLOAD REPORT

HEOR publications to guide managed care decisions

Increased focus on value-based pricing means that life sciences companies need to embrace the “volume-to-value” shift in their organizational DNA. The pressure to systematically demonstrate RWE-based value as medical publications is more significant than ever before – critical to ensuring desired pricing, coverage, and reimbursement throughout the product’s lifecycle.

A sound HEOR capability is crucial for publication planning to guide decision-makers on meeting global patient-access demands.

Read Blog / Crucial HEOR analytics for the cardiovascular community

Benefits

Fully customizable and transparent cost-effectiveness model for a pre-launch drug.

A budget impact model to assess the financial consequences of drug adoption from payers’ perspective.

Estimated RWE-based disease prevalence for granular patient segments using an optimization algorithm.

Meeting the global HEOR demands with strategic partnership and analytics

A growing need for HEOR

Increasing value-based assessments
Disparate evidence generation and poor management
Increasing RWE consumers across commercial functions
Increasing pricing pressure-driven value demonstration need

Axtria’s HEOR capabilities

Evidence publications management across the product life cycle
Robust data management expertise across real-world data sets
Advanced health economics publications and evaluation modeling skills
Clinical expertise and value assessment-driven budget impact models

High-impact solutions offered

Patient-level simulation

Test and analyze complex treatment outcomes on various types of patients with our patient-level simulations, supported with real-world and clinical trials data.

Cost-effectiveness models

Ensure cost-effectiveness to maximize the chances of drug approval with our customized and analytically rigorous models. These models are transparent and adaptable for global stakeholders.

Clinical trial simulations

Make informed decisions for clinical trial design with Axtria’s trial simulations. Ensure cost-effective analyses and reduced iterations across varying scenarios for continued product benefits.

The burden of disease analysis

Get detailed insights into the cost, morbidity, mortality, and unmet needs associated with multiple treatment options to maximize patient well-being and cost-effectiveness.

Real-world data experience

Experience RWE-based insights, using real-world and anonymized patient-level data to make educated decisions on various treatment options and their actual outcomes.

Managed markets and HEOR analytics

Unveil market complexities with Axtria’s deep domain and strategy consulting expertise in managed markets and hands-on experience with traditional and emerging datasets in this space.

Differentiated modeling studies

What-makes-axtrias-HEOR-modeling-studies-unique-GreenBG-3

Domain knowledge

Technical expertise

Customizability and agility

Innovation

Deep understanding and experience of diverse data sets
Deep therapeutic area expertise

A team of experienced modelers, statisticians, and academic writers
Extensive HEOR/RWE modeling experience

Proactive engagement with key stakeholders to design easily scalable and adaptable models
Statistically robust and clinically sound models

Design solutions that can withstand scrutiny during evidence dissemination
Continuous efforts towards implementing disruptive modeling approaches

Axtria research hub

White Paper

The Evolution and Future of Integrated Evidence Planning

Learn more

Webinar

Evidence Generation: Evolution and Future of Integrated Evidence Planning

Learn more

Report

HEOR Value Demonstration And Evidence Generation Challenges

Learn more

Customer success stories

Case Study

Automated Email Campaigns Support The Patient Assistance Journey For Enhanced Treatment Outcomes

Learn more

Case Study

Patient Flow Analysis For A Global Oncology Leader

Learn more

Case Study

Predictive Analytics For A Healthcare Company To Improve Patient Care

Learn more

Health Economics and Outcomes Research (HEOR)

Health economics and outcomes research (HEOR)

HEOR publications to guide managed care decisions

Benefits

Fully customizable and transparent cost-effectiveness model for a pre-launch drug.

A budget impact model to assess the financial consequences of drug adoption from payers’ perspective.

Estimated RWE-based disease prevalence for granular patient segments using an optimization algorithm.